S. Fukuzumi, S. Itoh et al.
FULL PAPER
NCH2CH(CH3)Ph, NCH2CH2Py, NCH2CH2Py), 7.00 (d, J=7.8 Hz, 2H;
ion): m/z: 407.9 [M+]; elemental analysis (%) calcd for C23H28O4.5N3-
H
H
Py-3), 7.11 (ddd, J=7.5, 6.0, 0.9 Hz, 2H; HPy-5), 7.16 (d, J=7.5 Hz, 2H;
Ph-2, HPh-2’), 7.19 (t, J=7.5 Hz, 1H; HPh-4), 7.28 (t, J=7.5 Hz, 2H; HPh-3
CuCl: C 53.38, H 5.45, N 8.12; found: C 53.61, H 5.42, N 8.00.
[CuI(L1Cl)]ClO4 (1Cl) was prepared in 59% yield in a similar manner to
the synthesis of 1OMe by treating L1Cl (109.8 mg, 0.3 mmol) with
[CuI(CH3CN)4]ClO4 (96.1 mg, 0.3 mmol). All procedures were performed
in a glove box ([O2]<0.1 ppm). 1H NMR (600 MHz, CD2Cl2, 278C): d=
2.77 (t, J=6.2 Hz, 2H; NCH2CH2Ar), 2.9 3.2 (brm, 10H; NCH2CH2Ar,
NCH2CH2Py, NCH2CH2Py), 7.11 (d, J=8.1 Hz, 2H; HAr-2 and HAr-2’),
7.30 (d, J=8.1 Hz, 2H; HAr-3, HAr-3’), 7.35 7.40 (m, 4H; HPy-3, HPy-5), 7.84
(t, J=7.5 Hz, 2H; HPy-4), 8.22 ppm (br, 2H; HPy-6); 13C NMR (600 MHz,
CD2Cl2, 278C): 32.53 (NCH2CH2Ar), 34.35 (NCH2CH2Py), 54.68
(NCH2CH2Py), 56.27 (NCH2CH2Ar), 123.71 (CPy-5), 126.31 (CAr-2), 126.37
(CPy-3), 129.14 (CAr-3), 133.12 (CAr-4), 134.60 (CAr-1), 139.23 (CPy-4), 150.36
(CPy-6), 160.44 ppm (CPy-2); FT-IR (KBr): n˜ =1121, 1089, 625 cmꢀ1
(ClO4ꢀ); ESI-MS (positive ion.): m/z: 428.0 [M+]; elemental analysis (%)
calcd for C22H24O4N3CuCl2: C 49.96, H 4.57, N 7.94; found: C 49.92, H,
4.77, N, 7.61.
,
HPh-3’), 7.54 (td, J=7.7, 1.9 Hz, 2H; HPy-4), 8.52 ppm (d, J=4.2, Hz, 2H;
H
36.08 (NCH2CH2Py), 38.79 (NCH2CH(CH3)Ph), 54.73 (NCH2CH2Py),
62.68 (NCH2CH(CH3)Ph), 121.33 (CPy-5), 123.82 (CPy-3), 126.22 (CPh-4),
127.72 (CPh-2), 128.53 (CPh-3), 136.46 (CPy-4), 146.95 (CPh-1), 149.26 (CPy-6),
161.28 ppm (CPy-2).
Py-6); 13C NMR (600 MHz, CD2Cl2, 278C): 19.98 (NCH2CH(CH3)Ph),
1
L3: H NMR (600 MHz, CD2Cl2, 278C): d=2.81 (dd, J=7.9, 6.8 Hz, 4H;
NCH2CH2Py), 2.97 (dd, J=7.9, 6.8 Hz, 4H; NCH2CH2Py), 3.20 (d, J=
7.7 Hz, 2H; NCH2CHPh2), 4.15 (t, J=7.7 Hz, 1H; NCH2CHPh2), 6.87 (d,
J=7.8 Hz, 2H; HPy-3), 7.08 (ddd, J=7.4, 4.9, 1.1 Hz, 2H; HPy-5), 7.18 (tt,
J=7.8, 1.3 Hz, 2H; HPh-4), 7.21 (dd, J=7.1, 1.3 Hz, 4H; HPh-2, HPh-2’), 7.26
(td, J=7.3, 1.9 Hz, 4H; HPh-3, HPh-3’), 7.49 (ddd, J=7.8, 7.4, 1.8 Hz, 2H;
HPy-4), 8.50 ppm (ddd, J=4.9, 1.8, 0.8 Hz, 2H; HPy-6); 13C NMR
(600 MHz, CD2Cl2, 278C): 35.95 (NCH2CH2Py), 50.17 (NCH2CHPh2),
54.49 (NCH2CH2Py), 60.19 (NCH2CHPh2), 121.24 (CPy-5), 123.67 (CPy-3),
126.45 (CPh-4), 128.62 (CPh-3), 128.63 (CPh-2), 136.27 (CPy-4), 144.53 (CPh-1),
149.45 (CPy-6), 161.28 ppm (CPy-2).
[CuI(L1NO )]ClO4 (1NO ) was prepared in 68% yield in a similar manner
2
2
to the synthesis of 1OMe by treating L1NO (112.9 mg, 0.3 mmol) with
2
[CuI(CH3CN)4]ClO4 (96.1 mg, 0.3 mmol). All procedures were performed
in a glove box ([O2]<0.1 ppm). 1H NMR (600 MHz, CD2Cl2, 278C): d=
2.86 (t, J=7.0 Hz, 2H; NCH2CH2Ar), 3.05 3.15 (br, 8H; NCH2CH2Py),
3.07 (t, J=7.0 Hz, 2H; NCH2CH2Ar), 7.33 (d, J=8.6 Hz, 2H; HAr-2, HAr-
2’), 7.38 (ddd, J=7.8, 5.4, 1.2 Hz, 2H; HPy-5), 7.41 (d, J=7.8 Hz, 2H; HPy-
3), 7.87 (td, J=7.8, 1.8 Hz, 2H; HPy-4), 8.11 (d, J=8.6 Hz, 2H; HAr-3, HAr-
3’), 8.37 ppm (ddd, J=5.4, 1.8, 0.8 Hz, 2H; HPy-6); 13C NMR (600 MHz,
CD2Cl2, 278C): 32.88 (NCH2CH2Ar), 34.83 (NCH2CH2Py), 55.04
(NCH2CH2Py), 56.83 (NCH2CH2Ar), 123.86 (CPy-5), 123.91 (CAr-3), 126.35
(CPy-3), 127.12 (CAr-2), 139.53 (CPy-4), 144.49 (CAr-4), 147.18 (CAr-1), 150.63
(CPy-6), 160.58 ppm (CPy-2); FT-IR (KBr): n˜ =1514, 1345 (NO2) 1113, 1089,
625 cmꢀ1 (ClO4ꢀ); ESI-MS (positive ion): m/z: 439.0 [M+]; elemental
analysis (%) calcd for C22H25O6.5N4CuCl: C 48.18, H 4.59, N 10.22;
found: C 48.41, H 4.50, N 10.07.
Caution! The perchlorate salts prepared in this study are all potentially
explosive and should be handled with care.
[CuI(L1OMe)]ClO4 (1OMe): L1OMe (108.4 mg, 0.3 mmol) was treated with
[CuI(CH3CN)4]ClO4 (96.1 mg, 0.3 mmol) in CH2Cl2 (5 mL) under an Ar
atmosphere. After stirring for 30 min at room temperature, insoluble ma-
terial was removed by filtration. Addition of diethyl ether (100 mL) to
the filtrate gave a pale yellow powder that precipitated on allowing the
mixture to stand for several minutes. The supernatant was then removed
by decantation, and the remaining pale yellow solid was washed with di-
ethyl ether three times and dried (68% yield). All procedures were per-
formed in a glove box (DBO-1 KP, Miwa Co. Ltd., [O2]<0.1 ppm).
1H NMR (600 MHz, CD2Cl2, 278C): d=2.73 (brm, 2H; NCH2CH2Ar),
2.8 3.3 (brm, 10H; NCH2CH2Ar, NCH2CH2Py, NCH2CH2Py), 3.77 (s, 3
H; OCH3), 6.89 (d, J=8.4 Hz, 2H; HAr-3, HAr-3’), 7.11 (d, J=8.4 Hz, 2H;
[CuI(L2)]ClO4 (2): Synthetic procedure, mass spectrum, and elemental
analysis of this compound were reported previously.[19] The NMR data re-
corded with a Bruker Avance 600 spectrometer in CD2Cl2 are as follows:
1H NMR (600 MHz, CD2Cl2, 278C): d=1.20 (d, J=6.9 Hz, 3H;
NCH2CH(CH3)Ph), 2.63 (dd, J=12.9, 4.2 Hz, 1H; NCH2CH(CH3)Ph),
2.75 (br, 1H; NCH2CH2Py), 2.80 (br, 1H; NCH2CH2Py), 2.85 (br, 1H;
NCH2CH2Py), 2.93 (br, 1H; NCH2CH2Py), 2.95 (br, 1H; NCH2CH2Py),
2.98 (m, 1H; NCH2CH(CH3)Ph), 3.13 (brt, J=12.0 Hz, 1H;
NCH2CH2Py), 3.23 (brt, J=14.6 Hz, 1H; NCH2CH2Py), 3.30 (brt, J=
11.7 Hz, 1H; NCH2CH2Py), 3.44 (t, J=12.9 Hz, 1H; NCH2CH(CH3)Ph),
7.18 (d, J=7.6 Hz, 2H; HPh-2, HPh-2’), 7.21 (br, 1H; HPy-5), 7.31 (br, 1H;
H
Ar-2, HAr-2’), 7.37, (br, 4H; HPy-3, HPy-5), 7.82 (brt, J=7.0 Hz, 2H; HPy-4),
8.19 ppm (br, 2H; HPy-6); 13C NMR (600 MHz, CD2Cl2, 278C): 32.49
(NCH2CH2Ar), 34.04 (NCH2CH2Py), 54.56 (NCH2CH2Py), 55.88
(OCH3), 56.28 (NCH2CH2Ar), 114.54 (CAr-3), 123.59 (CPy-5), 125.18 (CAr-
2), 126.64 (CPy-3), 126.29 (CAr-1), 138.86 (CPy-4), 150.13 (CPy-6), 159.33 (CAr-
4), 160.43 ppm (CPy-2); FT-IR (KBr): n˜ =1247, 1028 (OCH3) 1115, 1089,
625 cmꢀ1 (ClO4ꢀ); ESI-MS (positive ion), m/z: 424.0 [M+]; elemental
analysis (%) calcd for C23H27O5N3CuCl: C 52.67, H 5.19, N 8.01; found:
C 52.38, H 5.23, N 7.95.
[CuI(L1H)]ClO4 (1H): Synthetic procedure, mass spectrum, and elemental
analysis of this compound were reported previously.[41] The NMR data re-
corded on a Bruker Avance 600 spectrometer in CD2Cl2 are as follows:
1H NMR (600 MHz, CD2Cl2, 278C): d=2.82 (t, J=6.1 Hz, 2H;
NCH2CH2Ph), 3.18 (t, J=6.1 Hz, 2H; NCH2CH2Ph), 2.8 3.2 (brm, 8H;
NCH2CH2Py, NCH2CH2Py), 7.18 (d, J=7.5 Hz, 2H; HPh-2 and HPh-2’),
7.30 (m, 2H; HPy-5), 7.31 (t, J=7.5 Hz, 1H; HPh-4), 7.33 (d, J=7.8 Hz, 2
H; HPy-3), 7.38 (t, J=7.5 Hz, 2H; HPh-3, HPh-3’), 7.79 (t, J=7.8, 1.8 Hz, 2H;
H
H
Py-3), 7.33 (t, J=7.6 Hz, 1H; HPh-4), 7.36 (br, 1H; HPy-5), 7.37 (br, 1H;
Py-3), 7.39 (t, J=7.6 Hz, 2H; HPh-3, HPh-3’), 7.76 (br, 1H; HPy-4), 7.80 (br,
1H; HPy-4), 7.94 (br, 1H; HPy-6), 8.04 ppm (br, 1H; HPy-6); 13C NMR
(600 MHz,
CD2Cl2,
278C):
20.93
(NCH2CH(CH3)Ph),
33.63
(NCH2CH2Py), 33.98 (NCH2CH2Py), 38.96 (NCH2CH(CH3)Ph), 55.33
(NCH2CH2Py), 62.45 (NCH2CH(CH3)Ph), 121.24 (CPh-2), 123.37 (CPy-5),
123.66 (CPy-5’), 126.04 (CPy-3), 126.25 (CPy-3’), 127.61 (CPh-4), 129.45 (CPh-3),
138.81 (CPh-1), 138.96 (CPy-4), 149.87 (CPy-6), 150.28 (CPy-6’), 160.27 ppm
(CPy-2).
H
Py-4), 8.08 ppm (d, J=4.1 Hz, 2H; HPy-6); 13C NMR (600 MHz, CD2Cl2,
278C): 31.95 (NCH2CH2Ph), 34.03 (NCH2CH2Py), 54.54 (NCH2CH2Py),
56.02 (NCH2CH2Ph), 123.37 (CPy-3), 123.57 (CPh-2), 127.40 (CPy-5), 127.42
(CPh-4), 129.34 (CPhr-3), 138.90 (CPy-4), 134.71 (CPh-1), 150.23 (CPy-6),
160.30 ppm (CPy-2).
[CuI(L1Me)]ClO4 (1Me) was prepared in 56% yield in a similar manner to
the synthesis of 1OMe by treating L1Me (103.6 mg, 0.3 mmol) with
[CuI(CH3CN)4]ClO4 (96.1 mg, 0.3 mmol). All procedures were performed
[CuI(L3)]ClO4 (3) was prepared in 67% yield in a similar manner to the
synthesis of 1OMe by treating L3 (203.8 mg, 0.5 mmol) with
[CuI(CH3CN)4]ClO4 (160.1 mg, 0.5 mmol). All procedures were per-
formed in a glove box ([O2]<0.1 ppm). 1H NMR (600 MHz, CD2Cl2, 27
8C): d=2.90 (br, 2H; NCH2CH2Py), 3.08 (br, 2H; NCH2CH2Py), 3.15
(br, 4H; NCH2CH2Py, NCH2CH2Py), 3.38 (d, J=8.6 Hz, 2H;
NCH2CHPh2), 4.20 (t, J=8.6 Hz, 1H; NCH2CHPh2), 7.23 (br, 2H; HPh-4),
7.29 (m, 2H; HPy-5), 7.32 (m, 4H; HPh-2, HPh-2’), 7.35 (br, 4H; HPh-3, HPh-3’),
7.37 (m, 2H; HPy-3), 7.81 (td, J=7.8, 1.8 Hz, 2H; HPy-4), 7.95 ppm (ddd,
J=5.3, 0.9, 0.6 Hz, 2H; HPy-6); 13C NMR (600 MHz, CD2Cl2, 278C): 33.80
(NCH2CH2Py), 49.41 (NCH2CHPh2), 54.79 (NCH2CH2Py), 60.44
(NCH2CHPh2), 123.64 (CPy-5), 124.71 (CPh-2), 126.30 (CPy-3), 127.79 (CPh-4),
129.53 (CPh-3), 138.27 (CPh-1), 138.98 (CPy-4), 150.13 (CPy-6), 160.27 ppm
(CPy-2); FT-IR (KBr): n˜ =1115, 1089, 625 cmꢀ1 (ClO4ꢀ); FAB-MS(positive
ion): m/z: 470.1 [M+]; elemental analysis for [CuI(L3)]ClO4, calcd (%)
for C28H29O4N3CuCl: C 58.94, H 5.12, N 7.36; found: C 58.68, H 5.04, N
7.29.
1
in a glove box ([O2]< 0.1 ppm). H NMR (600 MHz, CD2Cl2, 278C): d=
2.32 (s, 3H; CH3), 2.76 (t, J=6.0 Hz, 2H; NCH2CH2Ar), 3.15 (t, J=
6.0 Hz, 2H; NCH2CH2Ar), 2.8 3.2 (brm, 8H; NCH2CH2Py,
NCH2CH2Py), 7.08 (d, J=7.8 Hz, 2H; HAr-2, HAr-2’), 7.18 (d, J=7.8 Hz, 2
H; HAr-3, HAr-3’), 7.32 (td, J=7.8, 1.1 Hz, 2H; HPy-5), 7.33 (d, J=7.8 Hz, 2
H; HPy-3), 7.80 (td, J=7.8, 1.8 Hz, 2H; HPy-4), 8.10 ppm (dt, J=7.8,
1.8 Hz, 2H; HPy-6); 13C NMR (600 MHz, CD2Cl2, 278C): 21.12 (CH3),
32.86 (NCH2CH2Ar), 32.98 (NCH2CH2Py), 54.55 (NCH2CH2Py), 56.38
(NCH2CH2Ar), 123.43 (CAr-2), 123.48 (CPy-5), 126.18 (CPy-3), 129.89 (CAr-3),
131.75 (CAr-1), 137.36 (CAr-4), 138.84 (CPy-4), 150.10 (CPy-6), 160.31 ppm
(CPy-2); FT-IR (KBr): n˜ =1112, 1089, 625 cmꢀ1 (ClO4ꢀ); ESI-MS (positive
244
¹ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2004, 10, 237 246